• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: MAQUET CARDIOPULMONARY GMBH OXYGENATORS; OXYGENATOR, CARDIOPULMONARY BYPASS

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

MAQUET CARDIOPULMONARY GMBH OXYGENATORS; OXYGENATOR, CARDIOPULMONARY BYPASS Back to Search Results
Model Number QUADROX-I ADULT
Device Problem Coagulation in Device or Device Ingredient (1096)
Patient Problem No Consequences Or Impact To Patient (2199)
Event Date 02/12/2020
Event Type  malfunction  
Manufacturer Narrative
A follow-up medwatch will be submitted when additional information becomes available.
 
Event Description
''oxy was blocked during the operation.There was no patient harm.I already have the oxy and the perfusion protocol.Lot oxy is requested''.(b)(4).
 
Manufacturer Narrative
The sample was requested for the technical investigation and it was received on 05.03.2020.During the investigation, a leak at the luer lock on the blood outlet side was found.Since the leak in the luer lock part was not reported by the customer, it can be concluded that the damage that caused this leak may have occurred during the transportation of the sample to the laboratory.No clots or another abnormality were detected.The failure regarding the clotting could not be confirmed.In addition the device history record for complaint (b)(4) and lot 70130097 and 92263001 have been reviewed.There are no evidences indicating a non conformance or deviations of the product in question during the manufacturing and final release of this specific lot.Trend search was performed and no systemic issue could be found.The reported failure was identified as part of the current risk management file (dms #(b)(4)).Mitigations for this specific failure are in place in instruction for use.Mitigations: ifu: no anticoagulation or insufficient anticoagulation causes occlusion of the extra corporeal circulation and the patient circuit.This can lead to inadequate patient support, hemolysis or thrombus formation in the patient.¿ weigh the benefits of extracorporeal circulation against the risk of systemic anticoagulation.¿ use anticoagulants; e.G.Heparin or argatroban.¿ check the effect of anticoagulants at regular intervals by measuring the act(activated clotting time).The act should not fall below 480 s.According to the ifu, it is the user's responsibility to ensure that the act level does not fall below 480.However, according to the information received, act level was observed to be 420.Moreover, the available information has been shared internally with getinge therapy application manager.It was stated that: the gas transfer rate was low during the end of the application, when the patient was rewarmed.The last act was 420sec.Therefore it is possible that the diffusion path became longer because of a fibrin layer on the gas fiber.The probable root cause is an insufficient anticoagulation.Since there are no evidences indicating a non conformance or deviations of the product in question , the failure could not be confirmed.The reported failure did not contribute to death or serious injury.At this time it cannot be concluded that this is a systemic error.Thus, no remedial action is required.No corrective action is needed.This complaint is being monitored as part of the complaint data trending of maquet cardiopulmonary gmbh and further investigations and measures will be conducted in case of adverse trending.
 
Event Description
Complaint: (b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
OXYGENATORS
Type of Device
OXYGENATOR, CARDIOPULMONARY BYPASS
Manufacturer (Section D)
MAQUET CARDIOPULMONARY GMBH
neue rottenburger strasse 37
hechingen
MDR Report Key9788143
MDR Text Key190539402
Report Number8010762-2020-00087
Device Sequence Number1
Product Code DTZ
Combination Product (y/n)N
PMA/PMN Number
K132829
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type company representative,health
Type of Report Initial,Followup
Report Date 02/27/2020
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/04/2020
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Health Professional
Device Expiration Date06/14/2021
Device Model NumberQUADROX-I ADULT
Device Catalogue Number70107.0061
Device Lot Number92263001
Date Manufacturer Received06/01/2020
Is This a Reprocessed and Reused Single-Use Device? Yes
Patient Sequence Number1
-
-